» Articles » PMID: 35533985

Estimating the Impact of Health Systems Factors on Antimicrobial Resistance in Priority Pathogens

Overview
Date 2022 May 9
PMID 35533985
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Antimicrobial resistance (AMR) is the next big pandemic that threatens humanity. The One Health approach to AMR requires quantification of interactions between health, demographic, socioeconomic, environmental, and geopolitical factors to design interventions. This study is focused on learning health system factors on global AMR.

Methods: This study analysed longitudinal data (2004-2017) of AMR having 6 33 820 isolates from 70 middle and high-income countries. We integrated AMR data with the Global Burden of Disease (GBD), Governance (WGI), and Finance data sets to find AMR's unbiased and actionable determinants. We chose a Bayesian decision network (BDN) approach within the causal modelling framework to quantify determinants of AMR. Further, we integrated Bayesian networks' global knowledge discovery approach with discriminative machine learning to predict individual-level antibiotic susceptibility in patients.

Results: From MAR (multiple antibiotic resistance) scores, we found a non-uniform spread pattern of AMR. Components-level analysis revealed that governance, finance, and disease burden variables strongly correlate with AMR. From the Bayesian network analysis, we found that access to immunization, obstetric care, and government effectiveness are strong, actionable factors in reducing AMR, confirmed by what-if analysis. Finally, our discriminative machine learning models achieved an individual-level AUROC (Area under receiver operating characteristic curve) of 0.94 (SE = 0.01) and 0.89 (SE = 0.002) to predict Staphylococcus aureus resistance to ceftaroline and oxacillin, respectively.

Conclusion: Causal machine learning revealed that immunisation strategies and quality of governance are vital, actionable interventions to reduce AMR.

Citing Articles

Global burden of bacterial skin diseases from 1990 to 2045: an analysis based on global burden disease data.

Gu J, Wang J, Li Y, Li L, Zou Y, Guo Y Arch Dermatol Res. 2025; 317(1):266.

PMID: 39820797 DOI: 10.1007/s00403-025-03804-z.


Non-Canonical Aspects of Antibiotics and Antibiotic Resistance.

Amabile-Cuevas C, Lund-Zaina S Antibiotics (Basel). 2024; 13(6).

PMID: 38927231 PMC: 11200725. DOI: 10.3390/antibiotics13060565.


Tackling the Antimicrobial Resistance "Pandemic" with Machine Learning Tools: A Summary of Available Evidence.

Rusic D, Kumric M, Seselja Perisin A, Leskur D, Bukic J, Modun D Microorganisms. 2024; 12(5).

PMID: 38792673 PMC: 11123121. DOI: 10.3390/microorganisms12050842.


Editorial: New drugs, approaches, and strategies to combat antimicrobial resistance.

Singh C, Sodhi K, Mubarak M Front Pharmacol. 2023; 14:1295623.

PMID: 38026960 PMC: 10657978. DOI: 10.3389/fphar.2023.1295623.